Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Work In Process (2016 - 2017)

Vanda Pharmaceuticals' Work In Process history spans 4 years, with the latest figure at $80000.0 for Q4 2017.

  • For Q4 2017, Work In Process rose 370.59% year-over-year to $80000.0; the TTM value through Dec 2017 reached $80000.0, up 370.59%, while the annual FY2017 figure was $80000.0, 370.59% up from the prior year.
  • Work In Process for Q4 2017 was $80000.0 at Vanda Pharmaceuticals, up from $63000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $1.8 million in Q2 2015 and bottomed at $7000.0 in Q2 2014.
  • The 4-year median for Work In Process is $71500.0 (2017), against an average of $564833.3.
  • The largest annual shift saw Work In Process skyrocketed 25300.0% in 2015 before it surged 370.59% in 2017.
  • A 4-year view of Work In Process shows it stood at $1.3 million in 2014, then increased by 19.0% to $1.6 million in 2015, then plummeted by 98.92% to $17000.0 in 2016, then soared by 370.59% to $80000.0 in 2017.
  • Per Business Quant, the three most recent readings for VNDA's Work In Process are $80000.0 (Q4 2017), $63000.0 (Q3 2017), and $131000.0 (Q2 2017).